NCT05585684View on ClinicalTrials.gov

Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy Selection

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

January 27, 2023

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Solid Tumor
Interventions
OTHER

Non-invasive Comprehensive Genomic Profiling for Cancer Treatment Selection

Use of liquid biopsy to evaluate the clinical utility of non-invasive comprehensive genomic profiling for cancer treatment selection.

Trial Locations (1)

21287

RECRUITING

Johns Hopkins University, Baltimore

Sponsors
All Listed Sponsors
collaborator

Personal Genome Diagnostics

INDUSTRY

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER